9-108898571-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003640.5(ELP1):​c.2294G>A​(p.Gly765Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.201 in 1,601,350 control chromosomes in the GnomAD database, including 35,513 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G765G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.26 ( 5950 hom., cov: 32)
Exomes 𝑓: 0.20 ( 29563 hom. )

Consequence

ELP1
NM_003640.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.95

Publications

35 publications found
Variant links:
Genes affected
ELP1 (HGNC:5959): (elongator acetyltransferase complex subunit 1) The protein encoded by this gene is a scaffold protein and a regulator for three different kinases involved in proinflammatory signaling. The encoded protein can bind NF-kappa-B-inducing kinase and I-kappa-B kinases through separate domains and assemble them into an active kinase complex. Mutations in this gene have been associated with familial dysautonomia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
ELP1 Gene-Disease associations (from GenCC):
  • primary dysautonomia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Riley-Day syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010578513).
BP6
Variant 9-108898571-C-T is Benign according to our data. Variant chr9-108898571-C-T is described in ClinVar as Benign. ClinVar VariationId is 137577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.407 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELP1NM_003640.5 linkc.2294G>A p.Gly765Glu missense_variant Exon 22 of 37 ENST00000374647.10 NP_003631.2 O95163Q4LE38Q8N516
ELP1NM_001318360.2 linkc.1952G>A p.Gly651Glu missense_variant Exon 22 of 37 NP_001305289.1 O95163A0A6Q8PGW3B4E3I9
ELP1NM_001330749.2 linkc.1247G>A p.Gly416Glu missense_variant Exon 20 of 35 NP_001317678.1 F5H2T0B3KNB2
ELP1XM_047423991.1 linkc.2294G>A p.Gly765Glu missense_variant Exon 22 of 25 XP_047279947.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELP1ENST00000374647.10 linkc.2294G>A p.Gly765Glu missense_variant Exon 22 of 37 1 NM_003640.5 ENSP00000363779.5 O95163

Frequencies

GnomAD3 genomes
AF:
0.259
AC:
39333
AN:
151928
Hom.:
5943
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.412
Gnomad AMI
AF:
0.265
Gnomad AMR
AF:
0.238
Gnomad ASJ
AF:
0.0741
Gnomad EAS
AF:
0.271
Gnomad SAS
AF:
0.218
Gnomad FIN
AF:
0.238
Gnomad MID
AF:
0.143
Gnomad NFE
AF:
0.186
Gnomad OTH
AF:
0.229
GnomAD2 exomes
AF:
0.221
AC:
55278
AN:
250044
AF XY:
0.213
show subpopulations
Gnomad AFR exome
AF:
0.423
Gnomad AMR exome
AF:
0.287
Gnomad ASJ exome
AF:
0.0837
Gnomad EAS exome
AF:
0.267
Gnomad FIN exome
AF:
0.233
Gnomad NFE exome
AF:
0.182
Gnomad OTH exome
AF:
0.195
GnomAD4 exome
AF:
0.195
AC:
283107
AN:
1449300
Hom.:
29563
Cov.:
30
AF XY:
0.194
AC XY:
139959
AN XY:
721712
show subpopulations
African (AFR)
AF:
0.420
AC:
13864
AN:
33012
American (AMR)
AF:
0.282
AC:
12598
AN:
44638
Ashkenazi Jewish (ASJ)
AF:
0.0836
AC:
2180
AN:
26078
East Asian (EAS)
AF:
0.279
AC:
11004
AN:
39508
South Asian (SAS)
AF:
0.195
AC:
16765
AN:
85920
European-Finnish (FIN)
AF:
0.228
AC:
12137
AN:
53260
Middle Eastern (MID)
AF:
0.127
AC:
685
AN:
5380
European-Non Finnish (NFE)
AF:
0.184
AC:
202169
AN:
1101570
Other (OTH)
AF:
0.195
AC:
11705
AN:
59934
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
10818
21636
32453
43271
54089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7278
14556
21834
29112
36390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.259
AC:
39376
AN:
152050
Hom.:
5950
Cov.:
32
AF XY:
0.260
AC XY:
19301
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.413
AC:
17095
AN:
41440
American (AMR)
AF:
0.238
AC:
3643
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0741
AC:
257
AN:
3470
East Asian (EAS)
AF:
0.271
AC:
1401
AN:
5170
South Asian (SAS)
AF:
0.216
AC:
1042
AN:
4820
European-Finnish (FIN)
AF:
0.238
AC:
2520
AN:
10574
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.186
AC:
12657
AN:
67974
Other (OTH)
AF:
0.227
AC:
480
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1413
2826
4240
5653
7066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
396
792
1188
1584
1980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.209
Hom.:
9307
Bravo
AF:
0.271
TwinsUK
AF:
0.189
AC:
702
ALSPAC
AF:
0.197
AC:
758
ESP6500AA
AF:
0.414
AC:
1820
ESP6500EA
AF:
0.182
AC:
1566
ExAC
AF:
0.224
AC:
27142
Asia WGS
AF:
0.263
AC:
912
AN:
3472
EpiCase
AF:
0.174
EpiControl
AF:
0.173

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial dysautonomia Benign:4
May 10, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jul 08, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
16
DANN
Benign
0.16
DEOGEN2
Benign
0.019
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.15
T;T
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
-2.1
N;.
PhyloP100
1.9
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
2.8
N;N
REVEL
Benign
0.11
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;.
Vest4
0.074
MPC
0.091
ClinPred
0.0027
T
GERP RS
4.0
Varity_R
0.10
gMVP
0.16
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230792; hg19: chr9-111660851; COSMIC: COSV65898003; API